Royal Bank Of Canada Celularity Inc Transaction History

Royal Bank Of Canada

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 14, 2024	SELL	$0.17 - $0.33 $719 - $1,397	-4,235 Reduced 1.85%	225,000 $56,000
Q3 2023 Nov 14, 2023	BUY	$0.22 - $0.56 $931 - $2,371	4,235 Added 1.88%	229,235 $50,000
Q2 2023 Aug 14, 2023	SELL	$0.42 - $0.81 $1,504 - $2,900	-3,581 Reduced 1.57%	225,000 $119,000
Q1 2023 May 15, 2023	BUY	$0.56 - $1.15 $120,714 - $247,896	215,562 Added 1655.75%	228,581 $141,000
Q4 2022 Feb 14, 2023	BUY	$1.08 - $2.35 $11,578 - $25,194	10,721 Added 466.54%	13,019 $16,000
Q3 2022 Nov 14, 2022	BUY	$0.43 - $4.31 $950 - $9,525	2,210 Added 2511.36%	2,298 $5,000
Q2 2022 Aug 15, 2022	SELL	$2.81 - $12.91 $3,737 - $17,170	-1,330 Reduced 93.79%	88 $0
Q1 2022 May 16, 2022	BUY	$3.81 - $9.79 $5,402 - $13,882	1,418 New	1,418 $13,000

23.6M

Ticker CELU
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 142,424,000
Market Cap $319M
Description
Celularity Inc., a clinical-stage biotechnology company, develops off-the-shelf placental-derived allogeneic cell therapies for the treatment of cancer, immune, and infectious diseases. It operates through three segments: Cell Therapy, Degenerative Disease, and BioBanking. The company's lead therapeutic programs include CYCART-19, a placental-de...

Get notified when there are updates to the investment portfolio of Royal Bank Of Canada, based on Form 13F filings with the SEC.

Stay updated on Royal Bank Of Canada with notifications on news.